4
Changes in Ownership
COLLEGIUM PHARMACEUTICAL, INC Filed Acc 0001062993-24-011338
EVP & Chief Commercial Officer sold 108,016 shares at an average $33.91 ($3,662,548)
- EVP & Chief Commercial Officer acquired 75,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Dreyer Scott · EVP & Chief Commercial Officer
Table I: Non-derivative
4 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2024-05-23 | Exercise or conversion : show line 1 in the form | +51,209 | $24.03 | $1,230,552 | 190,127 | D |
| 2024-05-23 | Sale : show line 2 in the form | −51,209 | $33.82 | $1,732,093 | 138,918 | D |
| 2024-05-24 | Exercise or conversion : show line 3 in the form | +23,791 | $24.03 | $571,698 | 162,709 | D |
| 2024-05-24 | Sale : show line 4 in the form | −56,807 | $33.98 | $1,930,455 | 105,902 | D |
| Open-market sales · 108,016 sh · avg $33.91 · $3,662,548 | ||||||
Table II: Derivative
2 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2024-05-23 | Exercise or conversion : show line 5 in the form Stock Option (Right to Purchase) | −51,209 | 23,791 | D |
| 2024-05-24 | Exercise or conversion : show line 6 in the form Stock Option (Right to Purchase) | −23,791 | 0 | D |
Loading xslF345X05/form4.xml…